Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Eur J Clin Nutr ; 70(5): 642-4, 2016 05.
Article in English | MEDLINE | ID: mdl-26838593

ABSTRACT

There are no standardised serving/portion sizes defined for foods consumed in the European Union (EU). Typical serving sizes can deviate significantly from the 100 g/100 ml labelling specification required by the EU legislation. Where the nutritional value of a portion is specified, the portion size is determined by the manufacturers. Our objective was to investigate the potential for standardising portion sizes for specific foods, thereby ensuring complementarity across countries. We compared portion size for 156 food items measured using a food frequency questionnaire across the seven countries participating in the Food4me study. The probability of consuming a food and the frequency of consumption differed across countries for 93% and 58% of the foods, respectively. However, the individual country mean portion size differed from the average across countries in only 16% of comparisons. Thus, although dietary choices vary markedly across countries, there is much less variation in portion sizes. Our results highlight the potential for standardisation of portion sizes on nutrition labels in the EU.


Subject(s)
Diet Surveys/statistics & numerical data , Feeding Behavior , Food Labeling/standards , Food/statistics & numerical data , Nutrition Policy , Portion Size/statistics & numerical data , Eating , Europe , Food Labeling/statistics & numerical data , Humans , Nutritive Value , Portion Size/standards
2.
Food Funct ; 6(3): 972-80, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25666373

ABSTRACT

Enzymatically hydrolysed milk proteins have a variety of biofunctional effects some of which may be beneficial in the management of type 2 diabetes mellitus. The purpose of this study was to evaluate the effect of commercially available intact and hydrolysed whey protein ingredients (DH 32, DH 45) on markers of the enteroinsular axis (glucagon like peptide-1 secretion, dipeptidyl peptidase IV inhibition, insulin secretion and antioxidant activity) before and after simulated gastrointestinal digestion (SGID). A whey protein hydrolysate, DH32, significantly enhanced (P < 0.05) insulin secretion from BRIN BD11 ß-cells compared to the positive control (16.7 mM glucose and 10 mM Ala). The whey protein hydrolysates inhibited dipeptidyl peptidase IV activity, yielding half maximal inhibitory concentration values (IC50) of 1.5 ± 0.1 and 1.1 ± 0.1 mg mL(-1) for the DH 32 and DH 45, samples respectively, and were significantly more potent than the intact whey (P < 0.05). Enzymatic hydrolysis of whey protein significantly enhanced (P < 0.05) its antioxidant activity compared to intact whey, as measured by the oxygen radical absorbance capacity assay (ORAC). This antioxidant activity was maintained (DH 32, P > 0.05) or enhanced (DH 45, P < 0.05) following SGID. Intact whey stimulated GLP-1 secretion from enteroendocrine cells compared to vehicle control (P < 0.05). This data confirm that whey proteins and peptides can act through multiple targets within the enteroinsular axis and as such may have glucoregulatory potential.


Subject(s)
Diabetes Mellitus, Type 2/metabolism , Dietary Supplements , Enteroendocrine Cells/metabolism , Hypoglycemic Agents/metabolism , Insulin-Secreting Cells/metabolism , Protein Hydrolysates/metabolism , Whey Proteins/metabolism , Animals , Biomarkers/metabolism , Cell Line , Chemical Phenomena , Diabetes Mellitus, Type 2/diet therapy , Dietary Supplements/analysis , Digestion , Dipeptidyl-Peptidase IV Inhibitors/chemistry , Dipeptidyl-Peptidase IV Inhibitors/metabolism , Dipeptidyl-Peptidase IV Inhibitors/therapeutic use , Glucagon-Like Peptide 1/agonists , Glucagon-Like Peptide 1/metabolism , Hypoglycemic Agents/chemistry , Hypoglycemic Agents/therapeutic use , Insulin/agonists , Insulin/metabolism , Insulin Secretion , Kinetics , Mice , Oxidants/chemistry , Oxidants/metabolism , Oxidants/therapeutic use , Oxidative Stress , Protein Hydrolysates/chemistry , Protein Hydrolysates/therapeutic use , Rats , Whey Proteins/chemistry , Whey Proteins/therapeutic use
3.
Nutr Metab Cardiovasc Dis ; 24(9): 996-1003, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24875672

ABSTRACT

BACKGROUND AND AIMS: Consumption of foods that modulate inflammatory stress in genetically-prone individuals may influence development of cardiometabolic diseases. Isoflavones in soy-derived foods function as phytoestrogens, have antioxidant and anti-inflammatory activity, inhibit protein-tyrosine kinase activity, and may be atheroprotective. We examined the relationship between soy food consumption and inflammatory responses to endotoxemia, postprandial responses to oral lipid tolerance test (OLTT), and insulin sensitivity from frequently sampled intravenous tolerance tests (FSIGTT). METHODS AND RESULTS: We administered low-dose endotoxin (LPS 1 ng/kg) to induce transient endotoxemia in young, healthy volunteers (N = 215) of African (AA), and European (EA) ancestry as part of the GENE Study. We further supported these findings in two independent samples: the MECHE Study and NHANES. Soy food consumption was a significant predictor of peak cytokine response following LPS. Individuals with moderate-high (>1.48 mg/day, N = 65) vs. low-no (<1.48 mg/day, N = 150) isoflavone consumption had significantly higher tumor necrosis factor alpha (TNFα) post-LPS (AUC, P = 0.009). Further, high-isoflavone consumers were protected against inflammation-induced decline in insulin sensitivity (SI) in GENE. We observed significant differences by soy consumption in the interferon gamma (IFNγ) response to OLTT, and the insulin response to OGTT in MECHE, as well as significantly lower fasting insulin, and 2-hour glucose post-OGTT in EA NHANES subjects. CONCLUSION: We demonstrate that soy consumption may influence inflammatory and metabolic responses. In research of nutritional exposures, measuring evoked phenotypes may be more informative than describing resting characteristics. The GENE Study was registered under NCT00953667 and the MECHE Study under NCT01172951, both at clinicaltrials.gov.


Subject(s)
Cardiovascular Diseases/prevention & control , Inflammation/prevention & control , Isoflavones/administration & dosage , Adolescent , Adult , Black or African American , Anti-Inflammatory Agents/administration & dosage , Antioxidants/administration & dosage , Blood Glucose/metabolism , Body Mass Index , Female , Healthy Volunteers , Homeostasis/drug effects , Humans , Insulin Resistance , Linear Models , Lipopolysaccharides/administration & dosage , Male , Middle Aged , Nutrition Surveys , Phytoestrogens/administration & dosage , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Randomized Controlled Trials as Topic , Soy Foods/analysis , Tumor Necrosis Factor-alpha/metabolism , White People , Young Adult
4.
Mol Vis ; 15: 985-99, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19461988

ABSTRACT

PURPOSE: Considerable evidence indicates a role for methionine sulfoxide reductase A (MsrA) in lens cell resistance to oxidative stress through its maintenance of mitochondrial function. Correspondingly, increased protein methionine sulfoxide (PMSO) is associated with lens aging and human cataract formation, suggesting that loss of MsrA activity is associated with this disease. Here we tested the hypothesis that loss of MsrA protein repair is associated with cataract formation. To test this hypothesis we examined the effect of MsrA deletion on lens opacity in mice treated with hyperbaric oxygen, identified lens mitochondrial proteins oxidized upon deletion of MsrA and determined the ability of MsrA to repair the identified proteins. METHODS: Wild-type and MsrA knockout mice were treated or not treated with 100 treatments of hyperbaric oxygen (HBO) over an 8 month period and lenses were examined by in vivo light scattering measurements documented by slit-lamp imaging. Co-immunoprecipitation of MsrA was conducted against five specific protein representatives of the five complexes of the electron transport chain in addition to cytochrome c (cyt c). Cyt c in lens protein from the knockout and wild-type lenses was subjected to cyanogen bromide (CNBr) cleavage to identify oxidized methionines. Methionine-specific CNBr cleavage was used to differentiate oxidized and un-oxidized methionines in cyt c in vitro and the ability of MsrA to restore the activity of oxidized cyt c was evaluated. Mass spectrometry analysis of cyt c was used to confirm oxidation and repair by MsrA in vitro. RESULTS: HBO treatment of MsrA knockout mice led to increased light scattering in the lens relative to wild-type mice. MsrA interacted with four of the five complexes of the mitochondrial electron transport chain as well as with cyt c. Cyt c was found to be aggregated and degraded in the knockout lenses consistent with its oxidation. In vitro analysis of oxidized cyt c revealed the presence of two oxidized methionines (met 65 and met 80) that were repairable by MsrA. Repair of the oxidized methionines in cyt c restored the activity of cytochrome c oxidase and reduced cytochrome c peroxidase activity. CONCLUSIONS: These results establish that MsrA deletion causes increased light scattering in mice exposed to HBO and they identify cyt c as oxidized in the knockout lenses. They also establish that MsrA can restore the in vitro activity of cyt c through its repair of PMSO. These results support the hypothesis that MsrA is important for the maintenance of lens transparency and provide evidence that repair of mitochondrial cyt c by MsrA could play an important role in defense of the lens against cataract formation.


Subject(s)
Cataract/metabolism , Cytochromes c/metabolism , Hyperbaric Oxygenation/adverse effects , Oxidoreductases/metabolism , Animals , Cataract/etiology , Cataract/genetics , Cell Line , Disease Models, Animal , Gene Deletion , Humans , Lens, Crystalline/cytology , Light , Methionine/analogs & derivatives , Methionine/metabolism , Methionine Sulfoxide Reductases , Mice , Mice, Knockout , Mitochondrial Proteins/metabolism , Oxidation-Reduction , Oxidative Stress , Oxidoreductases/genetics , Scattering, Radiation , Spectrometry, Mass, Electrospray Ionization
5.
Br J Nutr ; 84(2): 195-202, 2000 Aug.
Article in English | MEDLINE | ID: mdl-11029970

ABSTRACT

There is a wealth of epidemiological information on antioxidants and their possible prevention of disease progression but very little of the research on antioxidants has involved intervention studies. In this study, the potential protective effect of vitamin C or E supplementation in vivo against endogenous and H2O2-induced DNA damage levels in lymphocytes was assessed. The supplementation involved fourteen healthy male and female non-smokers mean age 25-53 (SD 1.82) years, who were asked to supplement an otherwise unchanged diet with 1000 mg vitamin C daily for 42 d or 800 mg vitamin E daily for 42 d. DNA damage in H2O2-treated peripheral blood lymphocytes (PBL) and untreated PBL before and after supplementation, and during a 6-week washout period was assessed using an ELISA. At each sampling time-point, the red cell concentrate activities of superoxide dismutase, catalase and glutathione peroxidase were also determined. Supplementation with vitamin C or vitamin E decreased significantly H2O2-induced DNA damage in PBL, but had no effect on endogenous levels of DNA damage. The activities of the antioxidant enzymes superoxide dismutase and glutathione peroxidase were suppressed during the supplementation period. These supplementation regimens may be used to limit the possible adverse effects of reactive oxygen species (including those produced during the course of an immune response) on lymphocytes in vivo, and so help to maintain their functional capacity.


Subject(s)
Ascorbic Acid/pharmacology , DNA Damage/physiology , Dietary Supplements , Lymphocytes/drug effects , Vitamin E/pharmacology , Adult , Antioxidants/pharmacology , Ascorbic Acid/blood , Catalase/metabolism , Female , Glutathione Peroxidase/metabolism , Humans , Hydrogen Peroxide/toxicity , Male , Superoxide Dismutase/metabolism , Vitamin E/blood
SELECTION OF CITATIONS
SEARCH DETAIL